Nipro newsletter April 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

DDL 2026
Merxin March 2026
Terumo 05/01
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026
Developing Healthcare Facilities
Regulatory & Marketplace V6I4

Developing Healthcare Facilities

If you are the operator of a nursing or care home, and you are considering commissioning the building of a new care or nursing home, or extending or refurbishing an ...
Continue Reading →
ISO IDMP – Four Challenges in Preparing Organisations for the July 1, 2016 EMA Deadline
Regulatory & Marketplace V6I4

ISO IDMP – Four Challenges in Preparing Organisations for the July 1, 2016 EMA Deadline

Most pharmaceutical companies face challenges in becoming compliant with the ISO IDMP standards. In this article, Rune Bergendorff, responsible for NNIT’s ISO IDMP s...
Continue Reading →
Regulatory & Marketplace V6I4

How Much Data Should You Include in a Patent Application?

In the life sciences and chemistry fields it is important to be aware that a perceived lack of data in a patent application can have an impact on the eventual scope ...
Continue Reading →
A Hard Pill to Swallow: Meeting the Needs of Modern Consumers
Regulatory & Marketplace V6I4

A Hard Pill to Swallow: Meeting the Needs of Modern Consumers

Confronted with the “patent cliff”, dwindling drug discovery success and a host of other challenges, pharmaceutical companies are being forced to reconsider how they...
Continue Reading →
Cost Savings for Healthcare Estates: Delivered through Improved Waste Management
Regulatory & Marketplace V6I4

Cost Savings for Healthcare Estates: Delivered through Improved Waste Management

You only have to read a newspaper or turn on the news to see how the NHS is struggling to meet the balance between demand for healthcare services and funding. Tony M...
Continue Reading →
“Personal Pill” Regulations: Current Landscape and Future Scenario
Regulatory & Marketplace V6I4

“Personal Pill” Regulations: Current Landscape and Future Scenario

The rapidly-evolving science of pharmacogenetics brought in the amazing concept of “personalisation of medicines” also referred to as the “personal pill”. Balamurali...
Continue Reading →
SMI London
Biopharma group march 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025